Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2013
10/31/2013WO2013126590A3 Pharmaceutical composition comprising cd34+ cells
10/31/2013WO2013120888A3 Core sheath drug delivery devices
10/31/2013WO2002087500A3 Viral enzyme activated prototoxophores and use of same to treat viral infections
10/31/2013WO2002078598A3 Peptides and antibodies to muc 1 proteins
10/31/2013US20130289520 Targeted and light-activated cytosolic drug delivery
10/31/2013US20130289244 Dock-and-Lock (DNL) Complexes for Delivery of Interference RNA
10/31/2013US20130289223 Polymeric coupling agents and pharmaceutically-active polymers made therefrom
10/31/2013US20130289207 Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotides
10/31/2013US20130289108 Palladium-Copper Catalysts for the Homogeneous Selective Oxidation of Thiol Groups
10/31/2013US20130289101 Therapy-enhancing glucan
10/31/2013US20130289069 Controlled Delivery System
10/31/2013US20130289065 Liquid pharmaceutical formulations of palonosetron
10/31/2013US20130289062 Compositions for deterring abuse of opioid containing dosage forms
10/31/2013US20130289055 Compressible, highly viscous polysaccharide and polyol powder
10/31/2013US20130289053 Depot formulations
10/31/2013US20130288991 Block copolymers for stable micelles
10/31/2013US20130288986 Polymer drug conjugates with tether groups for controlled drug delivery
10/31/2013US20130288949 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
10/31/2013US20130288333 Protein complex using an immunoglobulin fragment and method for the preparation thereof
10/31/2013US20130287847 Solid Molecular Dispersion
10/31/2013US20130287820 Oral delivery vehicle and material
10/31/2013US20130287819 Bioadhesive polymer-based controlled-release systems, production process and clinical uses thereof
10/31/2013US20130287817 Flowable implant with crosslinkable surface membrane
10/31/2013US20130287798 Uses of monoclonial antibody 8h9
10/31/2013US20130287744 Biocomposites And Methods Of Making The Same
10/31/2013US20130287734 Liquid formulations of long acting interferon alpha conjugate
10/31/2013US20130287729 Antigen-specific, tolerance-inducing microparticles and uses thereof
10/31/2013US20130287726 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
10/31/2013US20130287725 Biocompatible polymers, process for their preparation and compositions containing them
10/31/2013US20130287681 Somatostatin receptor-based cancer therapy
10/30/2013EP2657267A1 Bioactive surface capable of genetically modifying biological cells or tissues and use thereof
10/30/2013EP2657255A1 Aminated complex-type sugar chain derivatives and process for the production thereof
10/30/2013EP2657253A2 Anti-CD79b antibodies and immunoconjugates and methods of use
10/30/2013EP2657242A2 Amphiphilic cyclic phosphazene trimer, hydrophobic pharmaceutical formulation micellized by amphiphilic cyclic phosphazene trimer, and preparation methods thereof
10/30/2013EP2656860A1 Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
10/30/2013EP2656859A2 Compositions and methods for topical application and transdermal delivery of botulinum toxins
10/30/2013EP2656858A1 Transpulmonary liposome for controlling drug arrival
10/30/2013EP2656857A1 Oral liquid formulation
10/30/2013EP2656856A2 Tablet formulation comprising levodopa, carbidopa, entacapone providing extended release
10/30/2013EP2656849A1 Liposome comprising combination of chloroquine and adriamycin and preparation method thereof
10/30/2013EP2656846A1 Phosphomycin pharmaceutical composition
10/30/2013EP2656835A1 Long-lasting controlled-release liposome composition and method for producing same
10/30/2013EP2656833A1 Crosslinked Hyaluronic Acid Compositions For Tissue Augmentation
10/30/2013EP2655418A2 Anti-mesothelin antibodies and immunoconjugates
10/30/2013EP2655389A2 Compounds
10/30/2013EP2654799A1 Polymer-sunitinib conjugates
10/30/2013EP2654798A1 Use of aniline i the radiostabilization of oxime ligation
10/30/2013EP2654797A1 Polymer-des-ethyl sunitinib conjugates
10/30/2013EP2654796A1 Agents for clearing biomolecules from circulation
10/30/2013EP2654795A1 Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds
10/30/2013EP2654794A1 Materials and methods for conjugating a water soluble fatty acid derivative to a protein
10/30/2013EP2654788A1 Gas-filled microvesicles for use as vaccine
10/30/2013EP2654785A1 Enhanced immune response in bovine species
10/30/2013EP2654776A1 Use of pegylated recombinant human arginase for treatment of leukemia
10/30/2013EP2654738A1 Chewing gum composition comprising cross-linked polyacrylic acid
10/30/2013EP2654731A1 Solid retard formulations based on solid dispersions
10/30/2013EP2654728A1 Pharmaceutical composition containing active vegetable substances
10/30/2013EP2654725A2 Microparticles containing physiologically active peptide, method for preparing the same, and pharmaceutical composition comprising the same
10/30/2013EP2654724A2 Sustained-release polymeric microparticles containing poorly water-soluble drug and method for preparing the same
10/30/2013EP2654721A2 Pharmaceutical compositions of pyridinium and quinolinium derivatives
10/30/2013EP2654708A2 Cosmetic films
10/30/2013EP2654673A1 Fluid compositions comprising a structuring agent
10/30/2013EP2654670A2 Skin sanitizer compositions comprising alcohol based emulsion
10/30/2013EP2654637A1 Kit-in-parts for cleaning and treating ears of companion animals
10/30/2013CN1922199B CA6 antigen-specific cytotoxic conjugate and methods of using same
10/30/2013CN103380118A Tau成像探针 Tau imaging probe
10/30/2013CN103379920A Nanoparticles loaded with chemotherapeutic antitumoral drug
10/30/2013CN103379919A Leptin derivatives
10/30/2013CN103379918A Oral composition and method of forming and using same
10/30/2013CN103379917A Pharmaceutical compositions
10/30/2013CN103379915A HSA-related compositions and methods of use
10/30/2013CN103379904A Bromfenac aqueous liquid composition having preservative efficiency
10/30/2013CN103379903A Process for preparing nanoparticles of two polyamino acids of opposite charge, one of the two of which is in charge surplus
10/30/2013CN103379893A Carotenoid-containing composition and method for producing same
10/30/2013CN103374572A Sequence of aptamer of hepatoma cell and application thereof
10/30/2013CN103374208A Gradient degradable polymeric material and preparation method thereof
10/30/2013CN103374128A Amphiphilic triblock copolymer, polymer nano-carrier preparation and preparation methods
10/30/2013CN103374074A Anti-CD25 single-chain antibody
10/30/2013CN103372407A Preparation method of magnetic fluorescent composite nanospheres
10/30/2013CN103372220A Pharmaceutical microsphere for embolization
10/30/2013CN103372217A Polymer nano carrier preparation as well as preparation method and application thereof
10/30/2013CN103372216A Solid medical composition containing celecoxib
10/30/2013CN103372212A Quinazoline molecular targeted medicinal composition
10/30/2013CN103372199A Novel brain targeting preparation for preventing and treating neurodegenerative disease
10/30/2013CN103371983A Salbutamol sulfate controlled-release preparation based on corrosion infiltration mechanism
10/30/2013CN103371982A Novel prescription composition and preparation method of paroxetine hydrochloride enteric controlled release tablet
10/30/2013CN103371980A Dexamethasone sodium phosphate freeze-dried powder injection
10/30/2013CN103371979A Methylprednisolone sodium succinate freeze-dried powder injection
10/30/2013CN103371977A Tebipenem ester particles and preparation method thereof
10/30/2013CN103371976A Celecoxib-containing solid dispersion and preparation method thereof
10/30/2013CN103371975A Targeted long-circulation liposome preparation and preparation method thereof
10/30/2013CN103371974A Drug sustained release polymeric microspheres prepared based on micro-fluidic technology and application
10/30/2013CN103371973A Externally coated nanometer multiple emulsion for promoting oral absorption of insulin
10/30/2013CN103371971A Antiviral medicament for treating herpes simplex keratitis and method for preparing same
10/30/2013CN103371964A Preparation and application of gynecological pH-sensitive situ gel for vagina
10/30/2013CN103371315A Honey refining machine heated by adopting steam
10/30/2013CN103371313A Honey refining machine capable of preventing splashing
10/30/2013CN103371277A Stable food containing gold nanoparticles
10/30/2013CN102836394B Burn and scald ointment composition and burn and scald ointment, and preparation method thereof
10/30/2013CN102824642B Method for preparing starch-base carrier material for controlling slow-release through high-pressure retrogradation, prepared material and application
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 1712